Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03844919
Other study ID # REB18-0220
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2019
Est. completion date November 1, 2022

Study information

Verified date November 2021
Source University of Calgary
Contact Frank MacMaster, PhD
Phone 4039552784
Email fmacmast@ucalgary.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Tourette's Syndrome (TS) is characterized by repetitive movements and vocalizations called tics. Due to the suffering caused by TS, children and adolescents often require treatment for their tics. The investigators' research focuses on developing novel repetitive transcranial magnetic stimulation (rTMS) interventions for child and adolescent neuropsychiatric disorders. In this project, the investigators will determine the effect of pairing 3 weeks of rTMS and HRT on tic severity and plasticity as indexed by supplementary motor area (SMA) y-aminobutyric acid (GABA) concentration and functional connectivity of the SMA to the primary motor cortex (M1) in children and adolescents with TS. Children (N = 50, 6-18 years) with TS will be randomized to either a (1) rTMS+HRT arm, or (2) sham rTMS+HRT. Outcome measures will examine tic severity (primary), brain chemistry and function (secondary) at baseline and then at week 7. The investigators' proposed aims are: (Aim 1) To determine the effect of paired rTMS and HRT on tic severity as measured by the Yale Global Tic Severity Scale (YGTSS) by comparing it to sham rTMS + HRT. 1-1: The investigators hypothesize that tic severity will decrease from baseline to post-treatment. 1-2: The investigators also hypothesize that the reduction in tic severity will be greater in the paired treatment group (rTMS+HRT > Sham rTMS+HRT). (Aim 2) To determine the effect of paired rTMS and HRT on brain plasticity compared to sham rTMS + HRT. 2-1: The investigators hypothesize that patients treated with the paired rTMS and HRT will have a greater increase in GABA concentration comparted to sham and HRT. 2-2: The investigators also hypothesize that functional connectivity between the SMA and M1 will be greater with paired treatment (rTMS+HRT > Sham rTMS+HRT).


Description:

Tourette's Syndrome (TS) is characterized by repetitive movements and vocalizations called tics. Due to the suffering caused by TS, children and adolescents often require treatment for their tics. Tic severity predicts poor outcomes across physical, psychological, and cognitive domains in youth. Current treatments for TS remain limited in scope and efficacy. Atypical antipsychotics are often used and for many patients have an unacceptable side effect burden. Behavioral treatments, like habit reversal therapy (HRT), show promise and are safe, but are predicated on a certain level of brain maturation to execute. The investigators' research focuses on developing novel repetitive transcranial magnetic stimulation (rTMS) interventions for child and adolescent neuropsychiatric disorders. Plasticity, precision, and pairing are key considerations in this process. In this project, the investigators will determine the effect of pairing 3 weeks of rTMS and HRT on tic severity and plasticity as indexed by supplementary motor area (SMA) y-aminobutyric acid (GABA) concentration and functional connectivity of the SMA to the primary motor cortex (M1) in children and adolescents with TS. The investigators will use functional magnetic resonance imaging (fMRI) and robot controlled rTMS to precisely target the SMA. The investigators believe this pairing will provide improved relief by inducing plasticity to retrain the brain to be better at suppressing tics at an earlier age than usually expected. Children (N = 50, 6-18 years) with TS will be randomized to either a (1) rTMS+HRT arm, or (2) sham rTMS+HRT. Outcome measures will examine tic severity (primary), brain chemistry and function (secondary) at baseline and then at week 7. The investigators' proposed aims are: (Aim 1) To determine the effect of paired rTMS and HRT on tic severity as measured by the Yale Global Tic Severity Scale (YGTSS) by comparing it to sham rTMS + HRT. 1-1: The investigators hypothesize that tic severity will decrease from baseline to post-treatment. 1-2: The investigators also hypothesize that the reduction in tic severity will be greater in the paired treatment group (rTMS+HRT > Sham rTMS+HRT). (Aim 2) To determine the effect of paired rTMS and HRT on brain plasticity compared to sham rTMS + HRT. 2-1: The investigators hypothesize that patients treated with the paired rTMS and HRT will have a greater increase in GABA concentration comparted to sham and HRT. 2-2: The investigators also hypothesize that functional connectivity between the SMA and M1 will be greater with paired treatment (rTMS+HRT > Sham rTMS+HRT).


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date November 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria: 1. Diagnosis of Tourette's syndrome 2. IQ greater than 80 3. English fluency (to enable assent and consent). Exclusion Criteria: 1. Diagnosis of mania or schizophrenia 2. Impediments to TMS or MRI.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
rTMS + CBIT
Repetitive Transcranial Magnetic Stimulation (rTMS) parameters are: intensity 100% resting motor threshold (RMT), frequency 1Hz, duration = 30 minutes (1800 stimulations; 900 per side), target - the supplementary motor area (SMA). Treatments occur on weekdays (T - F) for four weeks (20 total). The Comprehensive Behavioral Intervention for Tics (CBIT) will be completed over eight sessions that will average 60 minutes in duration. First, participants will undergo awareness training. Participants will then be introduced to competing response training, which involves performing a voluntary behaviour designed to disrupt the execution of the tic. The eight sessions will occur on Mondays, once a week for six weeks and then on weeks 8 and 10.
Behavioral:
Sham rTMS + CBIT
Sham rTMS (sham coil) will be paired with CBIT. Sham rTMS will be delivered over the same time-frame as above. CBIT will be identical to the above.

Locations

Country Name City State
Canada Alberta Children's Hospital Calgary Alberta

Sponsors (2)

Lead Sponsor Collaborator
University of Calgary Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Yale Global Tic Severity Scale Total Tic score (YGTSS) post CBIT 30% reduction in YGTSS (~9 point reduction)
30% reduction in Yale Global Tic Severity Scale Total Tic score (YGTSS) (~9 point reduction).
A higher score on all scales suggests a more severe tics.
The YGTSS provides two tic severity scores:
Total Motor (0 to 25)
Total Phonic (0 to 25)
These are summed to form the Total Tic Severity Score (0 to 50). This is the measure for this outcome variable.
There is also the separate Impairment Dimension Score (0 to 50).
The total score is hence 0 to 100 (sum of Total Tic Severity Score and Impairment Dimension Score).
Baseline to week 11
Primary Yale Global Tic Severity Scale Total Tic score (YGTSS) 30% reduction in Yale Global Tic Severity Scale Total Tic score (YGTSS) (~9 point reduction).
A higher score on all scales suggests a more severe tics.
The YGTSS provides two tic severity scores:
Total Motor (0 to 25)
Total Phonic (0 to 25)
These are summed to form the Total Tic Severity Score (0 to 50). This is the measure for the primary outcome variable.
There is also the separate Impairment Dimension Score (0 to 50).
The total score is hence 0 to 100 (sum of Total Tic Severity Score and Impairment Dimension Score).
Baseline to week 7
Secondary Supplementary Motor Area (SMA) GABA concentration as measured by LCModel (Institutional Units) 10% increase in GABA concentration in the Supplementary Motor Area (SMA) as measured by LCModel (Institutional Units) Baseline to week 7
Secondary Functional connectivity of the Supplementary Motor Area (SMA) and the dominant Primary Motor Cortex (M1) Functional connectivity, as measured using SPM12, of the Supplementary Motor Area (SMA) and the dominant Primary Motor Cortex (M1). Baseline to week 7
See also
  Status Clinical Trial Phase
Recruiting NCT05370391 - Comprehensive Behavioral Intervention for Tics N/A
Completed NCT04007913 - Incorporating teleCBIT Into a Hospital-Based Tic Program N/A
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Completed NCT04498364 - Extinction Learning in Adults With Tourette Syndrome N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT00231985 - Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder Phase 2
Recruiting NCT06050369 - Objective Characterizatoion of Repetitive Behaviors N/A
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Completed NCT03483493 - Online Remote Behavioural Intervention for Tics (ORBIT) N/A
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Withdrawn NCT04765085 - Clinical Efficacy and Change of Life Quality Through Using the Comprehensive Behavioral Intervention Treatment for Tics N/A
Completed NCT02676492 - A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders N/A
Recruiting NCT01860300 - Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus N/A
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00056420 - Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement N/A
Completed NCT04128397 - An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disorder N/A
Recruiting NCT05547854 - Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program N/A
Completed NCT05047705 - Investigating Distress Tolerance in Adults With Tourette Syndrome N/A
Completed NCT03564132 - Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder Phase 2
Completed NCT03239210 - Effects of Ondansetron in Obsessive-compulsive and Tic Disorders Phase 4